abstract |
This disclosure relates to novel pharmaceutical compositions for administration of testosterone or testosterone derivatives using aqueous nasal administration. The disclosure also provides methods for treating diseases and disorders associated with fear and anxiety, decreased libido, or hypogonadism. |